It seems increasingly likely that President Obama’s last Food and Drug Administration commissioner, Robert Califf, will be going to work for Google biotech spinoff Verily Life Sciences.

Califf let slip in a talk to health care journalists earlier this month that he was considering joining Google, but did not elaborate. Then CNBC reported Tuesday, citing sources “familiar with the matter,” that Califf is talking with Verily about a leadership role. The job could still fall through, but would apparently involve a joint position at the Alphabet subsidiary and nearby Stanford University.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • call me biased, but I would say, it is all about having an illustrious insider knowledge on how to lobby and game the system.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy